- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | NewGenIvf Group beschließt Aktienzusammenlegung und Erhöhung der genehmigten Aktien | 4 | Investing.com Deutsch | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 01.07. | NewGenIvf explores $400 million real estate tokenization in UAE | 5 | Investing.com | ||
| 01.07. | NewGenIvf prüft Immobilien-Tokenisierung im Wert von 400 Millionen US-Dollar in den VAE | 8 | Investing.com Deutsch | ||
| 01.07. | NewGenIVF Group Limited: NewGen Subsidiary Secures Strategic UAE Land and Begins Exploration of Potential Real World Asset Tokenization Initiative | 171 | GlobeNewswire (Europe) | BANGKOK, July 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 01.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.06. | NewGenIVF Group Limited: NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market | 1 | GlobeNewswire (USA) | ||
| 04.06. | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 500 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
| 02.06. | NewGenIvf Plans To Invest $30 Mln In Solana | 2 | RTTNews | ||
| 02.06. | NewGenIvf to invest $30M in Solana staking; shares up | 3 | Seeking Alpha | ||
| 02.06. | NewGenIVF Group Limited: NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking | 204 | GlobeNewswire (Europe) | BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 02.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 20.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 01.05. | NewGenIvf kündigt Aktienzusammenlegung im Verhältnis 1:10 an | 3 | Investing.com Deutsch | ||
| 01.05. | NewGenIvf announces 1-for-10 reverse stock split | 1 | Investing.com | ||
| 01.05. | NewGenIVF Group Limited: NewGenIVF Announces Reverse Stock Split | 144 | GlobeNewswire (Europe) | BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 01.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 29.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 22.04. | NewGenIVF Group Limited: NewGen Filed 2024 Annual Report on Form 20-F | 2 | GlobeNewswire (USA) |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,103 | +0,98 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,800 | -0,99 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,009 | -2,37 % | PA GOODDOCTOR (01833): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
| CO-DIAGNOSTICS | 0,210 | -7,89 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| CYTOSORBENTS | 0,900 | -0,99 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,501 | -3,47 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| VOLITIONRX | 0,702 | +4,39 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 3,240 | +0,62 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
| IMUNON | 0,438 | -1,79 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
| BEYOND AIR | 2,600 | +1.369 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,487 | +2,10 % | Novacyt S.A. - Launch of LightBench® Discover | ||
| AROVELLA THERAPEUTICS | 0,061 | +11,01 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| MEMPHASYS | 0,004 | 0,00 % | MEMPHASYS LIMITED: Notice of General Meeting/Proxy Form |
NEWGENIVF GROUP LIMITED gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,044 (-7,00 %) liegt der Kurs bei 0,586 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.